Fig. 1From: The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysisTime to recurrence (a) and overall survival (b) according to KRAS status. KRAS mutation status had no impact on time to recurrence (p = 0.425) and overall survival (p = 0.137)Back to article page